Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

ClinicalTrials.gov ID: NCT07562152

Public ClinicalTrials.gov record NCT07562152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 6, 2026, 5:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination With the Modified Gemcitabine and Nab-Paclitaxel Regimen Versus the Standard Gemcitabine and Nab-Paclitaxel Regimen for the Treatment of Patients With Metastatic Pancreatic Ductal Pancreatic Adenocarcinoma Cancer (MAPKeeper 301)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Study identification

NCT ID
NCT07562152
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Immuneering Corporation
Industry
Enrollment
510 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2026
Primary completion
May 31, 2028
Completion
Jan 31, 2029
Last update posted
Sep 3, 2026

2026 – 2029

United States locations

U.S. sites
38
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Clearview Cancer Institute Huntsville Alabama 35805 Recruiting
City of Hope Phoenix Arizona 85338 Recruiting
City of Hope Duarte California 91010 Recruiting
Poudre Valley Health Care, Inc Fort Collins Colorado 80528 Recruiting
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 Recruiting
Medical Oncology Hematology Consultants Newark Delaware 19713 Recruiting
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952 Recruiting
Florida Cancer Specialists - South Sarasota Florida 34239 Recruiting
Florida Cancer Specialists - North St. Petersburg Florida 33701 Recruiting
Florida Cancer Specialists - East West Palm Beach Florida 33401 Recruiting
Piedmont Cancer Institute Atlanta Georgia 30318 Recruiting
Piedmont Healthcare Atlanta Georgia 30318 Recruiting
Illinois Cancer Specialists Arlington Heights Illinois 60005 Recruiting
City of Hope Chicago Illinois 60099 Recruiting
OSF Medical Center Peoria Illinois 61603 Recruiting
Maryland Oncology Columbia Maryland 21044 Recruiting
Missouri Cancer Associates Columbia Missouri 65201 Recruiting
Comprehensive Cancer Centers Las Vegas Nevada 89169 Recruiting
Regional Cancer Care Belleville New Jersey 07109 Recruiting
NYU Langone Health New York New York 10016 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
FirstHealth of the Carolinas Pinehurst North Carolina 28374 Recruiting
Taylor Cancer Research Center Maumee Ohio 43537 Recruiting
Willamette Valley Cancer Institute Eugene Oregon 97401 Recruiting
Thomas Jefferson University Philadelphia Pennsylvania 19107 Recruiting
Avera Cancer Institute Research Sioux Falls South Dakota 57105 Recruiting
West Cancer Center Germantown Tennessee 38138 Recruiting
Sarah Cannon Research Institute Nashville Tennessee 37203 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
Texas Oncology - West Texas Abilene Texas 79606 Recruiting
Texas Oncology - Austin Austin Texas 78705 Recruiting
Texas Oncology - San Antonio San Antonio Texas 78240 Recruiting
Texas Oncology Gulf Coast Webster Texas 77598 Recruiting
Blue Ridge Cancer Care Blacksburg Virginia 24060 Recruiting
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
University of Washington Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting
Northwest Cancer Specialists Vancouver Washington 98684 Recruiting
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07562152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07562152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →